LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Proception Medical – Ortho Innovations Incubator
Large Joints and Extremities

Proception Medical – Ortho Innovations Incubator

September 30, 2014 1 min read Premium comments

Advertisement

Proception Medical – Ortho Innovations Incubator
Source: Proception Medical, LLC
Secondary

Proception Medical, LLC is a medical device developer and incubator which, according to its founder, licenses commercially viable inventions from surgeon inventors, helps develop them, obtains the necessary commercialization approvals and then takes them through a limited launch. Proception has recently entered into exclusive agreements with two physician inventors for the development of their medical devices that are intended for the orthopedic extremity market.

Greg Kowalczyk, company principal and co-founder, said, ““Proception Medical is focusing on several therapeutic areas, but the orthopaedic extremity market, which is currently valued at $1.3 billion in the U.S. and is growing 10% per year, is a terrific target area for our first product entries. These first two products have tremendous clinical potential and together have the ability to improve the standard of care for over 832, 000 procedures annually in the U.S.” The procedures estimate is from iData Research.

Company officials plan to attend the annual meetings in Chicago of both the International Federation of Foot and Ankle Societies (IFFAS) and the American Orthopaedic Foot and Ankle Society (AOFAS) at the Hyatt Regency in late September. Kowalczyk reported that company management will be present at the society meetings assessing new invention opportunities and participating in strategic discussions with potential out-licensing commercialization partners.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy